Printer Friendly

Articles from Advances in Breast Cancer (June 1, 2007)

1-12 out of 12 article(s)
Title Author Type Words
2007 American Society of Clinical Oncology (ASCO) annual meeting. Barrett-Lee, Peter Conference notes 1059
Angiogenesis and breast cancer. Gillmore, Roopinder; Miles, David 2456
Breast cancer stem cells: potential therapeutic targets. Howell, Sacha J.; Farnie, Gillian; Clarke, Robert B. 2835
Cost-utility of adjuvant hormone therapies with aromatase inhibitors in postmenopausal women with breast cancer: upfront anastrozole, sequential tamoxifen-exemestane and tamoxifen-letrozole. Murray, Nick 573
HER-2, p53, p21 and hormonal receptors proteins expression as predictive factors of response and prognosis in locally advanced breast cancer treated with neoadjuvant docetaxel plus epirubicin combination. Barrett-Lee, Peter 316
HER2-directed therapies. Crabb, Simon J.; Chia, Stephen K. 6544
Impact of a 21-gene RT-PCR assay on treatment decisions in early-stage breast cancer. Murray, Nick 544
Initial versus sequential adjuvant aromatase inhibitor therapy: a review of the current data. Wardley, Andrew 530
Mechanisms of endocrine resistance. Leary, Alexandra; Johnston, Stephen 6275
Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial. Wardley, Andrew 577
Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion. Barrett-Lee, Peter 598
The role of targeted therapy in breast cancer. Wardley, Andrew Editorial 477

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |